Strategies aimed at preventing chronic post-surgical pain: Comprehensive perioperative pain management after total joint replacement surgery

Physiotherapy Canada

Volumn 63, Issue 3, 2011, Pages 289-304

  Clarke, Hance ^a,c   Woodhouse, Linda J ^b,c,e   Kennedy, Deborah ^b,c   Stratford, Paul ^c,e   Katz, Joel ^c,d  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b Orthopedic and Rehabilitation Services   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d YORK UNIVERSITY   (Canada)

^e MCMASTER UNIVERSITY   (Canada)

Author keywords

Chronic post surgical pain; Inter professional teams; Multi modal analgesia; Preventive analgesia; Total joint replacement

Indexed keywords

ANALGESIC AGENT;

ANALGESIA; CHRONIC PAIN; HUMAN; PAIN MEASUREMENT; PAIN, POSTOPERATIVE;

ANALGESICS; CHRONIC PAIN; HUMANS; PAIN MANAGEMENT; PAIN MEASUREMENT; PAIN, POSTOPERATIVE;

EID: 80051489644     PISSN: 03000508     EISSN: None     Source Type: Journal    
DOI: 10.3138/ptc.2009-49P     Document Type: Article

References (193)

1. Goldstein DH, Ellis J, Brown R, Wilson R, Penning J, Chisom K, et al. Recommendations for improved acute pain services: Canadian collaborative acute pain initiative. Pain Res Manag. 2004;9(3):123-30.
2. Stratford P, Dogra M, Woodhouse L, Kennedy D, Spadoni G. Validating self-report measures of pain and function in patients undergoing hip or knee arthroplasty. Physiother Can. 2009;61:189-94. doi:10.3138/physio.61.4.189
3. Stratford PW, Kennedy DM. Does parallel item content on WOMAC's pain and function subscales limit its ability to detect change in functional status? BMC Musculoskelet Disord. 2004;5:17. doi:10.1186/1471-2474-5-17
4. Ackerman IN, Dieppe PA, March LM, Roos EM, Nilsdotter AK, Brown GC, et al. Variation in age and physical status prior to total knee and hip replacement surgery: a comparison of centers in Australia and Europe. Arthritis Rheum. 2009;61(2):166-73. doi:10.1002/art.24215
5. O'Brien S, Bennett D, Doran E, Beverland DE. Comparison of hip and knee arthroplasty outcomes at early and intermediate follow-up. Orthopedics. 2009;32(3):168. doi:10.3928/01477447-20090301-21
6. Schein JR, Kosinski MR, Janagap-Benson C, Gajria K, Lin P, Freedman JD. Functionality and health-status benefits associated with reduction of osteoarthritis pain. Current Med Res Opin. 2008;24:1255-65. doi:10.1185/030079908X291912
7. Nikolajsen L, Brandsborg B, Lucht U, Jensen TS, Kehlet H. Chronic pain following total hip arthroplasty: a nationwide questionnaire study. Acta Anaesth Scand. 2006;50:495-500. doi:10.1111/j.1399- 6576.2006.00976.x
8. Birdsall PD, Hayes JH, Cleary R, Pinder IM, Moran CG, Sher JL. Health outcome after total knee replacement in the very elderly. J Bone Joint Surg Br. 1999;81:660-2. doi:10.1302/0301-620X.81B4.9380
9. Harris WH, Sledge CB. Total hip and total knee replacement (1). N Engl J Med. 1990;323:725-31. doi:10.1056/NEJM199009133231106
10. Kirwan JR, Currey HL, Freeman MA, Snow S, Young PJ. Overall long-term impact of total hip and knee joint replacement surgery on patients with osteoarthritis and rheumatoid arthritis. Rheumatology. 1994;33:357-60. doi:10.1093/rheumatology/33.4.357
11. Moran CG, Horton TC. Total knee replacement: the joint of the decade. A successful operation, for which there's a large unmet need. Brit Med J. 2000;320:820. doi:10.1136/bmj.320.7238.820
12. Rand JA, Ilstrup DM. Survivorship analysis of total knee arthroplasty: cumulative rates of survival of 9200 total knee arthroplasties. J Bone Joint Surg Am. 1991;73:397-409.
13. (Agency for Healthcare Research and Quality [AHRQ]. Total knee replacement (Summary report no. 86). Rockville (MD): The Agency; 2003 Dec [cited 2011 Jan 24]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK11960/
14. Dixon T, Shaw M, Ebrahim S, Dieppe P. Trends in hip and knee joint replacement: socioeconomic inequalities and projections of need. Ann Rheum Dis. 2004;63:825-30. doi:10.1136/ard.2003.012724
15. American Academy of Orthopaedic Surgeons. Orthopaedic-related statistics, 2003 [press release]. Available from: http://www6.aaos.org/news/pemr/releases/archives_byyear.cfm?archiveyear=2003.
16. Wells VM, Hearn TC, McCaul KA, Anderton SM, Wigg AE, Graves SE. Changing incidence of primary total hip arthroplasty and total knee arthroplasty for primary osteoarthritis. J Arthroplasty. 2002;17:267-73. doi:10.1054/arth.2002.30414
17. Puolakka TJ, Pajamaki KJ, Halonen PJ, Pulkkinen PO, Paavolainen P, Nevalainen JK. The Finnish Arthroplasty Register: report of the hip register. Acta Orthop Scand. 2001;72:433-41. doi:10.1080/000164701753532745
18. Robertsson O, Dunbar MJ, Knutson K, Lidgren L. Past incidence and future demand for knee arthroplasty in Sweden: a report from the Swedish Knee Arthroplasty Register regarding the effect of past and future population changes on the number of arthroplasties performed. Acta Orthop Scand. 2000;71:376-80. doi:10.1080/000164700317393376
19. Kurtz S, Mowat F, Ong K, Chan N, Lau E, Halpern M. Prevalence of primary and revision total hip and knee arthroplasty in the United States from 1990 through 2002. J Bone Joint Surg Am. 2005;87:1487-97. doi:10.2106/JBJS.D.02441
20. Calder JD, Ashwood N, Hollingdale JP. Survivorship analysis of the ''Performance'' total knee replacement-7-year follow-up. Int Orthop. 1999;23(2):100-3. doi:10.1007/s002640050317
21. Kennedy D, Stratford PW, Pagura SM, Walsh M, Woodhouse LJ. Comparison of gender and group differences in self-report and physical performance measures in total hip and knee arthroplasty candidates. J Arthroplasty. 2002;17:70-7. doi:10.1054/arth.2002.29324
22. König A, Walther M, Kirschner S, Gohlke F. Balance sheets of knee and functional scores 5 years after total knee arthroplasty for osteoarthritis: a source for patient information. J Arthroplasty. 2000;15:289-94. doi:10.1016/S0883-5403(00)90532-1
23. Walsh M, Woodhouse LJ, Thomas SG, Finch E. Physical impairments and functional limitations: a comparison of individuals 1 year after total knee arthroplasty with control subjects. Phys Ther. 1998;78:248-58.
24. Bourne RB, Chesworth BM, Davis AM, Mahomed NN, Charron KD. Patient satisfaction after total knee arthroplasty: who is satisfied and who is not? Clin Orthop Relat Res. 2009;468:57-63. doi:10.1007/s11999-009-1119-9
25. Melzack R, Wall P. The challenge of pain. 2nd ed. New York: Basic Books; 1988.
26. Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science. 2000;288:1765-9. doi:10.1126/science.288.5472.1765
27. Melzack R, Katz J. A conceptual framework for understanding pain in the human. In: Waldman SJ, editor. Pain management. New York: Elsevier Science; 2007. p. 2-9.
28. Costigan M, Scholz J, Woolf CJ. Neuropathic pain: a maladaptive response of the nervous system to damage. Ann Rev Neurosci. 2009;32:1-32. doi:10.1146/annurev.neuro.051508.135531
29. Fitzgerald M. The development of nociceptive circuits. Nat Rev Neurosci. 2005;6:507-20. doi:10.1038/nrn1701
30. Woolf CJ. Windup and central sensitization are not equivalent. Pain. 1996;66:105-8.
31. Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain. 2009;10:895-926. doi:10.1016/j.jpain.2009.06.012
32. Woolf CJ, Ma Q. Nociceptors-noxious stimulus detectors. Neuron. 2007;55:353-64. doi:10.1016/j.neuron.2007.07.016
33. Kelly DJ, Ahmad M, Brull SJ. Preemptive analgesia I: physiological pathways and pharmacological modalities. Can J Anaesth. 2001;48:1000-10.
34. Kehlet H, Jensen TS, Woolf CJ. Persistent postsurgical pain: risk factors and prevention. Lancet. 2006;367:1618-25. doi:10.1016/S0140-6736(06)68700-X
35. Rundshagen I, Kochs E, Schulte am Esch J. Surgical stimulation increases median nerve somatosensory evoked responses during isoflurane-nitrous oxide anaesthesia. Brit J Anaesth. 1995;75:598-602.
36. Abram SE, Yaksh TL. Morphine, but not inhalation anesthesia, blocks post-injury facilitation: the role of preemptive suppression of afferent transmission. Anesthesiology. 1993;78:713-21. doi:10.1097/00000542-199304000-00015
37. Strassels SA, McNicol E, Suleman R. Postoperative pain management: a practical review, part 2. Am J Health Syst Pharm. 2005;62:2019-25. doi:10.2146/ajhp040490.p2
38. Joshi GP. Multi-modal analgesia techniques and postoperative rehabilitation. Anesthesiol Clin N A. 2005;23(1):185-202. doi:10.1016/j.atc.2004.11.010
39. Brown AK, Christo PJ, Wu CL. Strategies for postoperative pain management. Best Pract Res An. 2004;18:703-17. doi:10.1016/j.bpa.2004.05.004
40. Hsieh M, Yealy DM. Are we ignoring the evidence? Acad Emerg Med. 2005;12:461-2. doi:10.1197/j.aem.2005.01.004
41. Marshall ML. Strategies for success: bringing evidence-based practice to the bedside. Clin Nurs Spec. 2006;20(3):124-7.
42. Gilron I, Bailey JM, Tu D, Holden RR, Weaver DF, Houlden RL. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med. 2005;352:1324-34. doi:10.1056/NEJMoa042580
43. Moiniche S, Hjortso NC, Hansen BL, Dahl JB, Rosenberg J, Gebuhr P, et al. The effect of balanced analgesia on early convalescence after major orthopaedic surgery. Acta Anaesth Scand. 1994;38:328-35.
44. Clarke H, Pereira S, Kennedy D, Gilron I, Katz J, Gollish J, et al. Gabapentin decreases morphine consumption and improves functional recovery following total knee arthroplasty. Pain Res Manag. 2009;14:217-22. doi:10.1016/j.acpain.2009.10.008
45. Horlocker TT, Kopp SL, Pagnano MW, Hebl JR. Analgesia for total hip and knee arthroplasty: a multi-modal pathway featuring peripheral nerve block. J Am Acad Orthop Surg. 2006;14(3):126-35.
46. Hebl JR, Dilger JA, Byer DE, Kopp SL, Stevens SR, Pagnano MW, et al. A pre-emptive multi-modal pathway featuring peripheral nerve block improves perioperative outcomes after major orthopedic surgery. Region Anesth Pain Med. 2008;33:510-7. doi:10.1016/j.rapm.2008.04.008
47. Barrington MJ, Olive DJ, McCutcheon CA, Scarff C, Said S, Kluger R, et al. Stimulating catheters for continuous femoral nerve blockade after total knee arthroplasty: a randomized, controlled, doubleblinded trial. Anesth Analg. 2008;106:1316-21. doi:10.1213/ane.0b013e318164efd1
48. Clarke H, Pereira S, Kennedy D, Andrion J, Mitsakakis N, Gollish J, et al. Adding gabapentin to a multi-modal regimen does not reduce acute pain, opioid consumption or chronic pain after total hip arthroplasty. Acta Anaesth Scand. 2009;53:1073-83. doi:10.1111/j.1399-6576.2009.02039.x
49. Wall PD. The prevention of postoperative pain. Pain. 1988;33:289-90. doi:10.1016/0304-3959(88)90286-2
50. Katz J. Pre-emptive analgesia: evidence, current status and future directions. Eur J Anaesth. 1995;10:8-13.
51. Coderre TJ, Katz J, Vaccarino AL, Melzack R. Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain. 1993;52:259-85. doi:10.1016/0304-3959(93)90161-H
52. Kissin I. Preemptive analgesia: terminology and clinical relevance. Anesth Analg. 1994;79:809-10.
53. Katz J, Clarke H. Preventive analgesia and beyond: current status, evidence, and future directions. In: Rice A, Macintyre P, Walker M, Rowbotham D, editors. Clinical pain management, 2nd ed. London: Hodder Arnold; 2008. p. 154-98.
54. Gordon SM, Brahim JS, Dubner R, McCullagh LM, Sang C, Dionne RA. Attenuation of pain in a randomized trial by suppression of peripheral nociceptive activity in the immediate postoperative period. Anesth Analg. 2002;95:1351-7. doi:10.1097/00000539-200211000-00047
55. Gundes H, Kilickan L, Gurkan Y, Sarlak A, Toker K. Short- and longterm effects of regional application of morphine and bupivacaine on the iliac crest donor site. Acta Orthop Belg. 2000;66:341-4.
56. Singh K, Phillips FM, Kuo E, Campbell M. A prospective, randomized, double-blind study of the efficacy of postoperative continuous local anesthetic infusion at the iliac crest bone graft site after posterior spinal arthrodesis: a minimum of 4-year follow-up. Spine. 2007;32:2790-6. doi:10.1097/BRS.0b013e31815b7650
57. McCartney CJ, Sinha A, Katz J. A qualitative systematic review of the role of N-methyl-D-aspartate receptor antagonists in preventive analgesia. Anesth Analg. 2004;98:1385-400. doi:10.1213/01.ANE.0000108501.57073.38h
58. Chia YY, Liu K, Wang JJ, Kuo MC, Ho ST. Intraoperative high dose fentanyl induces postoperative fentanyl tolerance. Can J Anaesth. 1999;46:872-7. doi:10.1007/BF03012978
59. Guignard B, Bossard AE, Coste C, Sessler DI, Lebrault C, Alfonsi P, et al. Acute opioid tolerance: intraoperative remifentanil increases postoperative pain and morphine requirement. Anesthesiology. 2000;93:409-17.
60. Kehlet H. Postoperative opioid sparing to hasten recovery: what are the issues? Anesthesiology. 2005;102:1083-5.
61. Yaksh TL, Dirig DM, Malmberg AB. Mechanism of action of nonsteroidal anti-inflammatory drugs. Cancer Invest. 1998;16:509-27. doi:10.3109/07357909809011705
62. Samad TA, Sapirstein A, Woolf CJ. Prostanoids and pain: unraveling mechanisms and revealing therapeutic targets. Trends Mol Med. 2002;8:390-6. doi:10.1016/S1471-4914(02)02383-3
63. Forrest JB, Camu F, Greer IA, Kehlet H, Abdalla M, Bonnet F, et al. Ketorolac, diclofenac, and ketoprofen are equally safe for pain relief after major surgery. Brit J Anaesth. 2002;88:227-33.
64. Kehlet H, Dahl JB. Are perioperative nonsteroidal anti-inflammatory drugs ulcerogenic in the short term? Drugs. 1992;44(Suppl 5):38-41. doi:10.2165/00003495-199200445-00006
65. Tramer MR, Williams JE, Carroll D, Wiffen PJ, Moore RA, McQuay HJ. Comparing analgesic efficacy of non-steroidal anti-inflammatory drugs given by different routes in acute and chronic pain: a qualitative systematic review. Acta Anaesth Scand. 1998;42:71-9. doi:10.1111/j.1399-6576.1998.tb05083.x
66. Derry P, Derry S, Moore RA, McQuay HJ. Single dose oral diclofenac for acute postoperative pain in adults. Cochrane Db Syst Rev;2009:2doi:10.1002/14651858.CD004768.pub2
67. Rapoport RJ. The safety of NSAIDs and related drugs for the management of acute pain: maximizing benefits and minimizing risks. Cancer Control. 1999;6(2 Suppl 1):18-21.
68. Gerstenfeld LC, Thiede M, Seibert K, Mielke C, Phippard D, Svagr B, et al. Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs. J Orthop Res. 2003;21:670-5. doi:10.1016/S0736-0266(03)00003-2
69. Buvanendran A, Kroin JS, Tuman KJ, Lubenow TR, Elmofty D, Moric M, et al. Effects of perioperative administration of a selective cyclooxygenase 2 inhibitor on pain management and recovery of function after knee replacement: a randomized controlled trial. J Am Med Assoc. 2003;290:2411-8. doi:10.1001/jama.290.18.2411
70. Huang YM, Wang CM, Wang CT, Lin WP, Horng LC, Jiang CC. Perioperative celecoxib administration for pain management after total knee arthroplasty-a randomized, controlled study. BMC Musculoskelet Disord. 2008;9:77. doi:10.1186/1471-2474-9-77
71. Meunier A, Aspenberg P, Good L. Celecoxib does not appear to affect prosthesis fixation in total knee replacement: a randomized study using radiostereometry in 50 patients. Acta Orthop. 2009;80(1):46-50. doi:10.1080/17453670902804976
72. Lapointe BM, Fremont P, Côté CH. Adaptation to lengthening contractions is independent of voluntary muscle recruitment but relies on inflammation. Am J Physiol Regul Integr Comp Physiol. 2002;282(1):R323-9.
73. Lapointe BM, Fremont P, Côté CH. Influence of nonsteroidal antiinflammatory drug treatment duration and time of onset on recovery from exercise-induced muscle damage in rats. Arch Phys Med Rehabil. 2003;84:651-5. doi:10.1016/S0003-9993(03)04899-2
74. Marsolais D, Côté CH, Frenette J. Nonsteroidal anti-inflammatory drug reduces neutrophil and macrophage accumulation but does not improve tendon regeneration. Lab Invest. 2003;83:991-9. doi:10.1097/01.LAB.0000078688.07696.AC
75. Gajraj NM, Joshi GP. Role of cyclooxygenase-2 inhibitors in postoperative pain management. Anesthesiol Clin N A. 2005;23(1):49-72. doi:10.1016/j.atc.2004.11.011
76. Gilron I, Milne B, Hong M. Cyclooxygenase-2 inhibitors in postoperative pain management: current evidence and future directions. Anesthesiology. 2003;99:1198-208.
77. Romsing J, Moiniche S. A systematic review of COX-2 inhibitors compared with traditional NSAIDs, or different COX-2 inhibitors for post-operative pain. Acta Anaesth Scand. 2004;48:525-46. doi:10.1111/j.0001-5172.2004.00379.x
78. Gajraj NM. The effect of cyclooxygenase-2 inhibitors on bone healing. Region Anesth Pain Med. 2003;28:456-65. doi:10.1016/j.rapm.2003.09.001
79. Jones SF, O'Donnell AM. Clinical pharmacology: traditional NSAIDS and selective COX-2 inhibitors. In: Macintyre P, Walker S, Rowbotham D, editors. Acute pain: clinical management, 2nd ed. London: Hodder Arnold; 2008. p. 68-93.
80. Toms L, Derry S, Moore RA, McQuay HJ. Single dose oral paracetamol (acetaminophen) with codeine for postoperative pain in adults. Cochrane Db Syst Rev;2009:1. doi:10.1002/14651858.CD001547.pub2
81. Duggan ST, Scott LJ. Intravenous paracetamol (acetaminophen). Drugs. 2009;69(1):101-13. doi:10.2165/00003495-200969010-00007
82. Southey ER, Soares-Weiser K, Kleijnen J. Systematic review and meta-analysis of the clinical safety and tolerability of ibuprofen compared with paracetamol in paediatric pain and fever. Curr Med Res Opin. 2009;25:2207-22. doi:10.1185/03007990903116255
83. Di Girolamo G, Sanchez AJ, De Los Santos AR, Gonzalez CD. Is acetaminophen, and its combination with pamabrom, an effective therapeutic option in primary dysmenorrhoea? Expert Opin Pharmaco. 2004;5:561-70. doi:10.1517/eoph.5.3.561.27364
84. Damen L, Bruijn JK, Verhagen AP, Berger MY, Passchier J, Koes BW. Symptomatic treatment of migraine in children: a systematic review of medication trials. Pediatrics. 2005;116(2):e295-302. doi:10.1542/peds.2004-2742
85. Hinz B, Brune K. Antipyretic analgesics: nonsteroidal antiinflammatory drugs, selective COX-2 inhibitors, paracetamol and pyrazolinones. Handb Experiment Pharmaco. 2007;177:65-93. doi:10.1007/978-3-540-33823-9_3
86. Towheed TE, Judd MJ, Hochberg MC, Wells G. Acetaminophen for osteoarthritis. Cochrane Db Syst Rev;2003:2 doi:10.1002/14651858.CD004257
87. Zhang W, Jones A, Doherty M. Does paracetamol (acetaminophen) reduce the pain of osteoarthritis? a meta-analysis of randomised controlled trials. Ann Rheum Dis. 2004;63:901-7.
88. Anderson BJ. Paracetamol (acetaminophen): mechanisms of action. Paediatr Anaesth. 2008;18:915-21. doi:10.1111/j.1460-9592.2008.02764.x
89. Botting R, Ayoub SS. COX-3 and the mechanism of action of paracetamol/acetaminophen. Prostag Leukotr Ess. 2005;72(2):85-7. doi:10.1016/j.plefa.2004.10.005
90. Chandrasekharan NV, Dai H, Roos KL, Evanson NK, Tomsik J, Elton TS, et al. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci USA. 2002;99:13926-31. doi:10.1073/pnas.162468699
91. Rezende RM, Franca DS, Menezes GB, dos Reis WG, Bakhle YS, Francischi JN. Different mechanisms underlie the analgesic actions of paracetamol and dipyrone in a rat model of inflammatory pain. Brit J Pharmacol. 2008;153:760-8. doi:10.1038/sj.bjp.0707630
92. Larson AM. Acetaminophen hepatotoxicity. Clin Liver Dis. 2007;11:525-48, vi. doi:10.1016/j.cld.2007.06.006
93. Barden J, Edwards J, Moore A, McQuay H. Single dose oral paracetamol (acetaminophen) for postoperative pain. Cochrane Db Syst Rev;2004:1. doi:10.1002/14651858.CD004602
94. Moore A, Collins S, Carroll D, McQuay H. Paracetamol with and without codeine in acute pain: a quantitative systematic review. Pain. 1997;70:193-201. doi:10.1016/S0304-3959(96)03319-2
95. McQuay HJ, Moore RA. Dose-response in direct comparisons of different doses of aspirin, ibuprofen and paracetamol (acetaminophen) in analgesic studies. Brit J Clin Pharmacol. 2007;63:271-8. doi:10.1111/j.1365-2125.2006.02723.x
96. Wienecke T, Gotzsche PC. Paracetamol versus nonsteroidal antiinflammatory drugs for rheumatoid arthritis. Cochrane Db Syst Rev;2004:1. doi:10.1002/14651858.CD003789.pub2
97. Schmid RL, Sandler AN, Katz J. Use and efficacy of low-dose ketamine in the management of acute postoperative pain: a review of current techniques and outcomes. Pain. 1999;82:111-25. doi:10.1016/S0304-3959(99)00044-5
98. Weinbroum AA, Rudick V, Paret G, Ben-Abraham R. The role of dextromethorphan in pain control. Can J Anaesth. 2000;47:585-96. doi:10.1007/BF03018952
99. Himmelseher S, Ziegler-Pithamitsis D, Argiriadou H, Martin J, Jelen-Esselborn S, Kochs E. Small-dose S({thorn})-ketamine reduces postoperative pain when applied with ropivacaine in epidural anesthesia for total knee arthroplasty. Anesth Analg. 2001;92:1290-5.
100. Wahlander S, Frumento RJ, Wagener G, Saldana-Ferretti B, Joshi RR, Playford HR, et al. A prospective, double-blind, randomized, placebo-controlled study of dexmedetomidine as an adjunct to epidural analgesia after thoracic surgery. J Cardiothorac Vasc Anesth. 2005;19:630-5. doi:10.1053/j.jvca.2005.07.006
101. Petrenko AB, Yamakura T, Baba H, Shimoji K. The role of Nmethyl- D-aspartate (NMDA) receptors in pain: a review. Anesth Analg. 2003;97:1108-16. doi:10.1213/01.ANE.0000081061.12235.55
102. Annetta MG, Iemma D, Garisto C, Tafani C, Proietti R. Ketamine: new indications for an old drug. Curr Drug Targets. 2005;6:789-94. doi:10.2174/138945005774574533
103. Berti M, Baciarello M, Troglio R, Fanelli G. Clinical uses of low-dose ketamine in patients undergoing surgery. Curr Drug Targets. 2009;10:707-15. doi:10.2174/138945009788982496
104. Adam F, Chauvin M, Du Manoir B, Langlois M, Sessler DI, Fletcher D. Small-dose ketamine infusion improves postoperative analgesia and rehabilitation after total knee arthroplasty. Anesth Analg. 2005;100:475-80. doi:10.1213/01.ANE.0000142117.82241.DC
105. Bilgin H, Ozcan B, Bilgin T, Kerimoglu B, Uckunkaya N, Toker A, et al. The influence of timing of systemic ketamine administration on postoperative morphine consumption. J Clin Anesth. 2005;17:592-7. doi:10.1016/j.jclinane.2005.04.005
106. Kafali H, Aldemir B, Kaygusuz K, Gursoy S, Kunt N. Small-dose ketamine decreases postoperative morphine requirements. Eur J Anaesth. 2004;21:916-7. doi:10.1017/S0265021504220282
107. Kwok RF, Lim J, Chan MT, Gin T, Chiu WK. Preoperative ketamine improves postoperative analgesia after gynecologic laparoscopic surgery. Anesth Analg. 2004;98:1044-9.
108. Duedahl TH, Romsing J, Moiniche S, Dahl JB. A qualitative systematic review of peri-operative dextromethorphan in post-operative pain. Acta Anaesth Scand. 2006;50:1-13. doi:10.1111/j.1399-6576.2006.00900.x
109. Cheng JK, Chiou LC. Mechanisms of the antinociceptive action of gabapentin. J Pharmacol Sci. 2006;100:471-86. doi:10.1254/jphs.CR0050020
110. Cheng VY, Bonin RP, Chiu MW, Newell JG, MacDonald JF, Orser BA. Gabapentin increases a tonic inhibitory conductance in hippocampal pyramidal neurons. Anesthesiology. 2006;105:325-33. doi:10.1097/00000542-200608000-00015
111. Dierking G, Duedahl TH, Rasmussen ML, Fomsgaard JS, Moiniche S, Romsing J, et al. Effects of gabapentin on postoperative morphine consumption and pain after abdominal hysterectomy: a randomized, double-blind trial. Acta Anaesth Scand. 2004;48:322-7. doi:10.1111/j.0001-5172.2004.0329.x
112. Fassoulaki A, Stamatakis E, Petropoulos G, Siafaka I, Hassiakos D, Sarantopoulos C. Gabapentin attenuates late but not acute pain after abdominal hysterectomy. Eur J Anaesth. 2006;23(2):136-41. doi:10.1017/S0265021505002048
113. Gilron I, Orr E, Tu D, O'Neill JP, Zamora JE, Bell AC. A placebocontrolled randomized clinical trial of perioperative administration of gabapentin, rofecoxib and their combination for spontaneous and movement-evoked pain after abdominal hysterectomy. Pain. 2005;113:191-200. doi:10.1016/j.pain.2004.10.008
114. Pandey CK, Priye S, Singh S, Singh U, Singh RB, Singh PK. Preemptive use of gabapentin significantly decreases postoperative pain and rescue analgesic requirements in laparoscopic cholecystectomy. Can J Anaesth. 2004;51:358-63.
115. Pandey CK, Singhal V, Kumar M, Lakra A, Ranjan R, Pal R, et al. Gabapentin provides effective postoperative analgesia whether administered pre-emptively or post-incision. Can J Anaesth. 2005;52:827-31.
116. Rorarius MG, Mennander S, Suominen P, Rintala S, Puura A, Pirhonen R, et al. Gabapentin for the prevention of postoperative pain after vaginal hysterectomy. Pain. 2004;110:175-81. doi:10.1016/j.pain.2004.03.023
117. Turan A, Karamanlioglu B, Memis D, Usar P, Pamukcu Z, Ture M. The analgesic effects of gabapentin after total abdominal hysterectomy. Anesth Analg. 2004;98:1370-3. doi:10.1213/01.ANE.0000108964.70485.B2
118. Turan A, White PF, Karamanlioglu B, Memis D, Tasdogan M, Pamukcu Z, et al. Gabapentin: an alternative to the cyclooxygenase- 2 inhibitors for perioperative pain management. Anesth Analg. 2006;102:175-81. doi:10.1213/01.ane.0000184824.43411.63h
119. Adam F, Menigaux C, Sessler DI, Chauvin M. A single preoperative dose of gabapentin (800 milligrams) does not augment postoperative analgesia in patients given interscalene brachial plexus blocks for arthroscopic shoulder surgery. Anesth Analg. 2006;103:1278-82. doi:10.1213/01.ane.0000237300.78508.f1
120. Leung JM, Sands LP, Rico M, Petersen KL, Rowbotham MC, Dahl JB, et al. Pilot clinical trial of gabapentin to decrease postoperative delirium in older patients. Neurology. 2006;67:1251-3. doi:10.1212/01.wnl.0000233831.87781.a9
121. Menigaux C, Adam F, Guignard B, Sessler DI, Chauvin M. Preoperative gabapentin decreases anxiety and improves early functional recovery from knee surgery. Anesth Analg. 2005;100:1394-9.
122. Pandey CK, Navkar DV, Giri PJ, Raza M, Behari S, Singh RB, et al. Evaluation of the optimal preemptive dose of gabapentin for postoperative pain relief after lumbar diskectomy: a randomized, double-blind, placebo-controlled study. J Neurosurg Anesth. 2005;17(2):65-8.
123. Pandey CK, Sahay S, Gupta D, Ambesh SP, Singh RB, Raza M, et al. Preemptive gabapentin decreases postoperative pain after lumbar discoidectomy. Can J Anaesth. 2004;51:986-9.
124. Radhakrishnan M, Bithal PK, Chaturvedi A. Effect of preemptive gabapentin on postoperative pain relief and morphine consumption following lumbar laminectomy and discectomy: a randomized, double-blinded, placebo-controlled study. J Neurosurg Anesth. 2005;17(3):125-8.
125. Turan A, Karamanlioglu B, Memis D, Hamamcioglu MK, Tukenmez B, Pamukcu Z, et al. Analgesic effects of gabapentin after spinal surgery. Anesthesiology. 2004;100:935-8. doi:10.1097/00000542-200404000-00025
126. Turan A, Kaya G, Karamanlioglu B, Pamukcu Z, Apfel CC. Effect of oral gabapentin on postoperative epidural analgesia. Brit J Anaesth. 2006;96:242-6. doi:10.1093/bja/aei294
127. Al-Mujadi H, Rafei AR, Katzarov MG, Dehrab NA, Batra YK, Al- Qattan AR. Preemptive gabapentin reduces postoperative pain and opioid demand following thyroid surgery. Can J Anaesth. 2006;53:268-73. doi:10.1007/BF03022214
128. Mikkelsen S, Hilsted KL, Andersen PJ, Hjortso NC, Enggaard TP, Jorgensen DG, et al. The effect of gabapentin on post-operative pain following tonsillectomy in adults. Acta Anaesth Scand. 2006;50:809-15. doi:10.1111/j.1399-6576.2006.01057.x
129. Turan A, Memis D, Karamanlioglu B, Yagiz R, Pamukcu Z, Yavuz E. The analgesic effects of gabapentin in monitored anesthesia care for ear-nose-throat surgery. Anesth Analg. 2004;99:375-8. doi:10.1213/01.ANE.0000136646.11737.7B
130. Dirks J, Fredensborg BB, Christensen D, Fomsgaard JS, Flyger H, Dahl JB. A randomized study of the effects of single-dose gabapentin versus placebo on postoperative pain and morphine consumption after mastectomy. Anesthesiology. 2002;97:560-4. doi:10.1097/00000542-200209000-00007\
131. Fassoulaki A, Patris K, Sarantopoulos C, Hogan Q. The analgesic effect of gabapentin and mexiletine after breast surgery for cancer. Anesth Analg. 2002;95:985-91. doi:10.1097/00000539-200210000-00036
132. Fassoulaki A, Triga A, Melemeni A, Sarantopoulos C. Multi-modal analgesia with gabapentin and local anesthetics prevents acute and chronic pain after breast surgery for cancer. Anesth Analg. 2005;101:1427-32. doi:10.1213/01.ANE.0000180200.11626.8E
133. Parsa AA, Sprouse-Blum AS, Jackowe DJ, Lee M, Oyama J, Parsa FD. Combined preoperative use of celecoxib and gabapentin in the management of postoperative pain. Aesthet Plast Surg. 2009;33:98-103. doi:10.1007/s00266-008-9230-y
134. Koc S, Memis D, Sut N. The preoperative use of gabapentin, dexamethasone, and their combination in varicocele surgery: a randomized controlled trial. Anesth Analg. 2007;105:1137-42. doi:10.1213/01.ane.0000278869.00918.b7
135. Huot MP, Chouinard P, Girard F, Ruel M, Lafontaine ER, Ferraro P. Gabapentin does not reduce post-thoracotomy shoulder pain: a randomized, double-blind placebo-controlled study. Can J Anaesth. 2008;55:337-43. doi:10.1007/BF03021488
136. Parlow J, Milne B, Gilron I, Shore D, Orr E. Gabapentin pharmacokinetics and feasibility in cardiac surgery [abstract no. 471869]. Proceedings of the Canadian Anesthesiology Society Meeting 2008; Kingston, Ontario.
137. Mathiesen O, Jacobsen LS, Holm HE, Randall S, Adamiec- Malmstroem L, Graungaard BK, et al. Pregabalin and dexamethasone for postoperative pain control: a randomized controlled study in hip arthroplasty. Brit J Anaesth. 2008;101:535-41. doi:10.1093/bja/aen215
138. Ho KY, Gan TJ, Habib AS. Gabapentin and postoperative pain-a systematic review of randomized controlled trials. Pain. 2006;126:91-101. doi:10.1016/j.acpain.2007.02.006
139. Peng PW, Wijeysundera DN, Li CC. Use of gabapentin for perioperative pain control-a meta-analysis. Pain Res Manag. 2007;12(2):85-92.
140. Seib RK, Paul JE. Preoperative gabapentin for postoperative analgesia: a meta-analysis. Can J Anaesth. 2006;53:461-9. doi:10.1007/BF03022618
141. Felson DT, Lawrence RC, Dieppe PA, Hirsch R, Helmick CG, Jordan JM, et al. Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med. 2000;133:635-46.
142. Guccione AA, Felson DT, Anderson JJ, Anthony JM, Zhang Y, Wilson PW, et al. The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am J Public Health. 1994;84:351-8. doi:10.2105/AJPH.84.3.351
143. Stratford PW, Kennedy DM. Performance measures were necessary to obtain a complete picture of osteoarthritic patients. J Clin Epidemiol. 2006;59(2):160-7. doi:10.1016/j.jclinepi.2005.07.012
144. Stratford PW, Kennedy DM, Woodhouse LJ. Performance measures provide assessments of pain and function in people with advanced osteoarthritis of the hip or knee. Phys Ther. 2006;86:1489-96. doi:10.2522/ptj.20060002
145. Boardman DL, Dorey F, Thomas BJ, Lieberman JR. The accuracy of assessing total hip arthroplasty outcomes: a prospective correlation study of walking ability and 2 validated measurement devices. J Arthroplasty. 2000;15:200-4.
146. Kreibich DN, Vaz M, Bourne RB, Rorabeck CH, Kim P, Hardie R, et al. What is the best way of assessing outcome after total knee replacement? Clin Orthop Relat Res. 1996;331:221-5. doi:10.1097/00003086-199610000-00031
147. Freter SH, Fruchter N. Relationship between timed ''up and go'' and gait time in an elderly orthopaedic rehabilitation population. Clin Rehabil. 2000;14(1):96-101. doi:10.1191/026921500675545616
148. Ouellet D, Moffet H. Locomotor deficits before and two months after knee arthroplasty. Arthritis Rheum. 2002;47:484-93. doi:10.1002/art.10652
149. Walsh M, Kennedy D, Stratford PW, Woodhouse LJ. Perioperative functional performance of women and men following total knee arthroplasty. Physiother Can. 2001;53:92-100.
150. Kennedy DM, Stratford PW, Wessel J, Gollish JD, Penney D. Assessing stability and change of four performance measures: a longitudinal study evaluating outcome following total hip and knee arthroplasty. BMC Musculoskelet Disord. 2005;6(3). doi:10.1186/1471-2474-6-3 151.
151. Dahl JB, Moiniche S, Kehlet H. Wound infiltration with local anaesthetics for postoperative pain relief. Acta Anaesth Scand. 1994;38:7-14. doi:10.1111/j.1399-6576.1994.tb03830.x
152. Kasibhatla RD, Russon K. Femoral nerve blocks. J Perioper Pract. 2009;19(2):65-9.
153. Kerr DR, Kohan L. Local infiltration analgesia: a technique for the control of acute postoperative pain following knee and hip surgery: a case study of 325 patients. Acta Orthop. 2008;79:174-83. doi:10.1080/17453670710014950
154. Ontario Ministry of Health and Long-Term Care [Internet]. Wait times in Ontario. Toronto: The Ministry; c 2009 [updated 2009 summer; cited 2010 summer]. Available from: http://www.health.gov.on.ca/transformation/wait_times/providers/wt_pro_mn.html.
155. Moiniche S, Mikkelsen S, Wetterslev J, Dahl JB. A systematic review of intra-articular local anesthesia for postoperative pain relief after arthroscopic knee surgery. Region Anesth Pain Med. 1999;24:430-7. doi:10.1016/S1098-7339(99)90010-X
156. Allen HW, Liu SS, Ware PD, Nairn CS, Owens BD. Peripheral nerve blocks improve analgesia after total knee replacement surgery. Anesth Analg. 1998;87:93-7. doi:10.1097/00000539-199807000-00020
157. Ben-David B, Schmalenberger K, Chelly JE. Analgesia after total knee arthroplasty: is continuous sciatic blockade needed in addition to continuous femoral blockade? Anesth Analg. 2004;98:747-9. doi:10.1213/01.ANE.0000096186.89230.56
158. Enneking FK, Chan V, Greger J, Hadzic A, Lang SA, Horlocker TT. Lower-extremity peripheral nerve blockade: essentials of our current understanding. Region Anesth Pain Med. 2005;30:4-35. doi:10.1016/j.rapm.2004.10.002
159. Weber A, Fournier R, Riand N, Gamulin Z. Duration of analgesia is similar when 15, 20, 25 and 30 mL of ropivacaine 0.5% are administered via a femoral catheter. Can J Anaesth. 2005;52:390-6. doi:10.1007/BF03016282
160. Boezaart AP. Perineural infusion of local anesthetics. Anesthesiology. 2006;104:872-80. doi:10.1097/00000542-200604000-00033
161. Evans H, Steele SM, Nielsen KC, Tucker MS, Klein SM. Peripheral nerve blocks and continuous catheter techniques. Anesthesiol Clin N A. 2005;23(1):141-62. doi:10.1016/j.atc.2004.11.003
162. Effects of perioperative analgesic technique on the surgical outcome and duration of rehabilitation after major knee surgery. Anesthesiology. 1999;91(1):8-15. doi:10.1097/00000542-199907000-00006
163. Singelyn FJ, Deyaert M, Joris D, Pendeville E, Gouverneur JM. Effects of intravenous patient-controlled analgesia with morphine, continuous epidural analgesia, and continuous three-in-one block on postoperative pain and knee rehabilitation after unilateral total knee arthroplasty. Anesth Analg. 1998;87(1):88-92. doi:10.1097/00000539-199807000-00019
164. Turk DC. A diathesis-stress model of chronic pain and disability following traumatic injury. Pain Res Manag. 2002;7(1):9-19.
165. Asmundson GJ, Norton PJ, Norton GR. Beyond pain: the role of fear and avoidance in chronicity. Clin Psychol Rev. 1999;19(1):97-119. doi:10.1016/S0272-7358(98)00034-8
166. Leeuw M, Goossens ME, van Breukelen GJ, Boersma K, Vlaeyen JW. Measuring perceived harmfulness of physical activities in patients with chronic low back pain: the Photograph Series of Daily Activities-short electronic version. J Pain. 2007;8:840-9. doi:10.1016/j.jpain.2007.05.013
167. Martin AL, Halket E, Asmundson GJ, Flora D, Katz J. Posttraumatic stress symptoms and the diathesis-stress model of chronic pain and disability in patients undergoing major surgery. Clin J Pain. 2010;26:518-27. doi:10.1097/AJP.0b013e3181e15b98
168. Blanchard DC, Blanchard RJ. Defensive behaviors, fear and anxiety. In: Blanchard RJ, Blanchard DC, Griebel G, Nutt D, editors. Handbook of fear and anxiety. Amsterdam: Elsevier; 2008. p. 63-79.
169. Crombez G, Vlaeyen JW, Heuts PH, Lysens R. Pain-related fear is more disabling than pain itself: evidence on the role of pain-related fear in chronic back pain disability. Pain. 1999;80:329-39.
170. Vlaeyen JW, Kole-Snijders AM, Boeren RG, van Eek H. Fear of movement/(re)injury in chronic low back pain and its relation to behavioral performance. Pain. 1995;62:363-72. doi:10.1016/0304- 3959(94)00279-N
171. Waddell G, Newton M, Henderson I, Somerville D, Main CJ. A Fear- Avoidance Beliefs Questionnaire (FABQ) and the role of fearavoidance beliefs in chronic low back pain and disability. Pain. 1993;52:157-68. doi:10.1016/0304-3959(93)90127-B
172. Fordyce WE. The cognitive/behavioral perspective on clinical pain. In: Loeser JD, Egan KJ, editors. Managing the chronic pain patient. New York: Raven Press; 1989. p. 51-64.
173. Philips HC. Avoidance behaviour and its role in sustaining chronic pain. Behav Res Ther. 1987;25:273-9. doi:10.1016/0005-7967(87)90005-2
174. Philips HC. The effects of behavioural treatment on chronic pain. Behav Res Ther. 1987;25:365-77. doi:10.1016/0005-7967(87)90014-3
175. Woods MP, Asmundson GJ. Evaluating the efficacy of graded in vivo exposure for the treatment of fear in patients with chronic back pain: a randomized controlled clinical trial. Pain. 2008;136:271-80. doi:10.1016/j.pain.2007.06.037
176. Boersma K, Linton S, Overmeer T, Jansson M, Vlaeyen J, de Jong J. Lowering fear-avoidance and enhancing function through exposure in vivo: a multiple baseline study across six patients with back pain. Pain. 2004;108:8-16. doi:10.1016/j.pain.2003.03.001
177. Vlaeyen JW, de Jong J, Geilen M, Heuts PH, van Breukelen G. The treatment of fear of movement/(re)injury in chronic low back pain: further evidence on the effectiveness of exposure in vivo. Clin J Pain. 2002;18:251-61.
178. Katz J, Seltzer Z. Transition from acute to chronic postsurgical pain: risk factors and protective factors. Expert Rev Neurother. 2009;9:723-44. doi:10.1586/ern.09.20
179. Kalkman CJ, Visser K, Moen J, Bonsel GJ, Grobbee DE, Moons KG. Preoperative prediction of severe postoperative pain. Pain. 2003;105:415-23. doi:10.1016/S0304-3959(03)00252-5
180. Poleshuck EL, Katz J, Andrus CH, Hogan LA, Jung BF, Kulick DI, et al. Risk factors for chronic pain following breast cancer surgery: a prospective study. J Pain. 2006;7:626-34. doi:10.1016/j.jpain.2006.02.007
181. Katz J, Melzack R. Psychological aspects of pain: implications for neural blockade. In: Cousins MJ, Carr D, Horlocker T, Bridenbaugh PO, editors. Cousins and Bridenbaugh's neural blockade, 4th ed. Philadelphia: Lippincott, Williams & Wilkins; 2009. p. 777-93.
182. Katz J, Buis T, Cohen L. Locked out and still knocking: predictors of excessive demands for postoperative intravenous patientcontrolled analgesia. Can J Anaesth. 2008;55:88-99. doi:10.1007/BF03016320
183. Forsythe ME, Dunbar MJ, Hennigar AW, Sullivan MJ, Gross M. Prospective relation between catastrophizing and residual pain following knee arthroplasty: two-year follow-up. Pain Res Manag. 2008;13:335-41.
184. Harden RN, Bruehl S, Stanos S, Brander V, Chung OY, Saltz S, et al. Prospective examination of pain-related and psychological predictors of CRPS-like phenomena following total knee arthroplasty: a preliminary study. Pain. 2003;106:393-400. doi:10.1016/j.pain.2003.08.009
185. Sullivan M, Tanzer M, Stanish W, Fallaha M, Keefe FJ, Simmonds M, et al. Psychological determinants of problematic outcomes following total knee arthroplasty. Pain. 2009;143:123-9. doi:10.1016/j.pain.2009.02.011
186. Katz J, Asmundson GJ, McRae K, Halket E. Emotional numbing and pain intensity predict the development of pain disability up to one year after lateral thoracotomy. Eur J Pain. 2009;13:870-8. doi:10.1016/j.ejpain.2008.10.003
187. Katz J. Pain begets pain-predictors of long-term phantom limb pain and post-thoracotomy pain. Pain Forum. 1997;6:140-4.
188. Perkins FM, Kehlet H. Chronic pain as an outcome of surgery: a review of predictive factors. Anesthesiology. 2000;93:1123-33.
189. Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP, Katz NP, et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain. 2005;113:9-19. doi:10.1016/j.pain.2004.09.012
190. Katz J, Cohen L. Preventive analgesia is associated with reduced pain disability 3 weeks but not 6 months after major gynecologic surgery by laparotomy. Anesthesiology. 2004;101:169-74. doi:10.1097/00000542-200407000-00026
191. Holland R, Harvey I. Population needs assessment and knee replacement surgery. Rheumatology. 2003;42:503-6. doi:10.1093/rheumatology/keg197
192. Iorio R, Robb WJ, Healy WL, Berry DJ, Hozack WJ, Kyle RF, et al. Orthopaedic surgeon workforce and volume assessment for total hip and knee replacement in the United States: preparing for an epidemic. J Bone Joint Surg Am. 2008;90:1598-605. doi:10.2106/JBJS.H.00067
193. Quintana JM, Escobar A, Arostegui I, Bilbao A, Armendariz P, Lafuente I, et al. Prevalence of symptoms of knee or hip joints in older adults from the general population. Aging Clin Exp Res. 2008;20:329-36